epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

epocrates

5h

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

Occup Environ Med

8h

Night shifts through pregnancy tied to more child screening flags

Whether a mother kept working nights or stopped partway through pregnancy may track with how her child fares on a screening at age four. . .

Brain

10h

New brain-computer interface gives unresponsive patients a voice

A bedside EEG-based brain-computer interface uncovered hidden consciousness and enabled thought-driven communication in some unresponsive patients. . .

Lancet

12h

Hormonal IUD placement during endometrial ablation reduces later hysterectomy risk

Two-year trial also found less need for bleeding medication and less cyclical pain. . .

CDC

13h

CDC ranks drug resistance threats, four of them urgent

The list also tracks how individual pathogens have moved, including one that dropped a tier and others that keep gaining ground among US patients. . .

ACOG

15h

GLP-1s and pregnancy: New ACOG guidance urges caution before conception and during breastfeeding

New guidance addresses preconception discontinuation, pregnancy avoidance, and individualized decisions during breastfeeding. . .

Ann Intern Med

16h

AI scribes cut documentation time, but don't boost productivity

Heavy users spent less time on notes, yet after-hours work and clinical output remained largely unchanged. . .

epocrates

16h

Test created by integration tests

Hadlima (adalimumab) - indicated for 1) moderate to severe rheumatoid arthritis in adult patients, 2) psoriatic arthritis in adult patients, 3) ankylosing spondylitis in adult patients, 4) moderate to severe Crohn disease in adult and pediatric patients 6 years and older, 5) various other indications.

N Engl J Med

1d

ESMO Congress 2026: Next-generation KRAS inhibitor outperforms rivals in lung cancer

Divarasib nearly doubled progression-free survival versus sotorasib or adagrasib and extended median overall survival to almost 18 months. . .

Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information